Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- FN +11.9%, CPST +7.1%, LITE +5.6%, SWKS +3%, (also announces $1 billion stock repurchase program), LII +2.8%, MU +2.5%, (raises Q2 guidance and announces Chief Financial Officer transition), OCLR +2.1%, PINC +2%, TM +1.3%, GM +1.2%, RE +1.1%,TDG +1.1%, SPGI +1%, VSM +0.8%, EMR +0.8%, AGN +0.8%, RBC +0.7%, ITUB +0.6%,APTI +0.5%
Other news:
- UVXY +50.9% (ProShares Ultra VIX Short-Term move higher continues in after hours)
- ASFI +39.9% (declares special cash dividend of $5.30 per common share)
- ARGS +14.7% (obtains option to license PD1 checkpoint inhibitors; to host call on tomorrow Feb 6 at 8:30am ET)
- AKTX +11% (announces additional data for its Phase II COBALT clinical trial and provides an update on other clinical trials with Coversin)
- BDSI +4.4% (announces BELBUCA patent litigation settlement agreement with Teva)
- NAK +1.9% (announces that the US Army Corps of Engineers selected the third-party contractor that will support them in completing an Environmental Impact Statement for the Pebble Project)
Analyst comments:
- MU +2.5% (upgraded to Overweight from Sector Weight at KeyBanc Capital Mkts)